Google快讯 - disease

	disease 实时更新 ⋅ 2023年5月1日
	新闻
	AAN 2023: Memantine fails to slow disease progression in Phase 2b trial - ALS News Today ALS News Today Memantine, an approved therapy for Alzheimer's disease, failed to slow disease progression for ALS patients in a Phase 2 trial. 标记为不相关
	4 reasons why slim people are at risk of fatty liver disease | The Times of India Times of India The most common cause of fatty liver disease is extra deposition of fat in the liver due to obesity or abnormal amount of visceral fat, that is, ... 标记为不相关
	A day in my life as a person managing Cushing's disease Cushing's Disease News This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈